No. 24A871

Vanda Pharmaceuticals, Inc. v. Food and Drug Administration, et al.

Lower Court: District of Columbia
Docketed: 2025-03-12
Status: Presumed Complete
Type: A
Experienced Counsel
Tags: None
Latest Conference: N/A

Question presented not available.

Docket Entries

2025-03-12
Application (24A871) granted by The Chief Justice extending the time to file until May 16, 2025.
2025-03-07
Application (24A871) to extend the time to file a petition for a writ of certiorari from March 17, 2025 to May 16, 2025, submitted to The Chief Justice.
Main DocumentLower Court Orders/OpinionsLower Court Orders/OpinionsProof of ServiceOtherMain DocumentLower Court Orders/OpinionsLower Court Orders/Opinions

Attorneys

Food and Drug Administration, et al.
Sarah M. Harris — Acting Solicitor General, Respondent
Sarah M. Harris — Acting Solicitor General, Respondent
Vanda Pharmaceuticals Inc.
Paul Whitfield Hughes — McDermott Will & Emery, Petitioner
Paul Whitfield Hughes — McDermott Will & Emery, Petitioner